Microbiome as a Target for Cancer Therapy

Area of Science:

• Oncology
• Microbiology
• Immunology

Background:

• The microbiome, particularly gut microbiota, plays a crucial role in regulating inflammatory, immune, and metabolic functions.
• Imbalances in gut microbiota composition are linked to the development and progression of various cancers.
• Cancer poses a significant socioeconomic burden, necessitating novel therapeutic approaches.

Purpose of the Study:

• To review the intricate relationship between the microbiome and cancer pathogenesis.
• To explore the impact of gut microbiota-targeted therapies on cancer pathologies.
• To discuss the potential of microbiota modulation as an adjuvant cancer treatment.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of studies investigating the role of gut microbiota in cancer.
• Examination of data on the efficacy of microbiota-modulating treatments in cancer.

Main Results:

• Gut microbiota dysbiosis is associated with increased cancer risk and progression.
• Microbiota-targeted interventions show promise in influencing cancer development.
• Modulating the gut microbiome may alleviate cancer treatment-related symptoms.

Conclusions:

• The gut microbiome is a critical factor in cancer biology.
• Targeting the gut microbiota represents a promising avenue for novel cancer therapies.
• Further research into microbiota modulation could revolutionize cancer treatment and patient outcomes.